Interleukin (IL) 17 expression in Iraqi bladder carcinoma patients
Author
Source
Iraqi Journal of Biotechnology
Issue
Vol. 16, Issue 3 (30 Sep. 2017), pp.94-97, 4 p.
Publisher
University of Baghdad Genetic Engineering and Biotechnology for Postgraduate Studies
Publication Date
2017-09-30
Country of Publication
Iraq
No. of Pages
4
Main Subjects
Abstract EN
Intcrlcukin (IL- 17) is pro inflammatory cytokincs produccd by CD4+ T-helpcrl7 (Thl7)ccll .It has a vital cffcct on cells of the immunc systcm playing crucial rôles in pathogcncsis of immunc-mcdiatcd discascs, likc-canccrs.
The eurrent study was designed to detcct the protein expression of IL-17 in Iraqi bladder carcinoma patients, and its corrélation with clinical grades.
Tissuc samplcs were collccted from 45 patients with bladder carcinoma.
The immunoexpression of IL-17 was dctcctcd by using IL-17 monoclonal antibody.
The results of Immunohistochcmical (IHC) studying showed that tissucs with positive (IL-17) expression were low in bladder cancer patients practically in low grades with signifieant différence, it is concludcd that IL-17 expression can bc used as indicators for procession in bladder cancer.
American Psychological Association (APA)
Musa, Hind Muzhir. 2017. Interleukin (IL) 17 expression in Iraqi bladder carcinoma patients. Iraqi Journal of Biotechnology،Vol. 16, no. 3, pp.94-97.
https://search.emarefa.net/detail/BIM-811018
Modern Language Association (MLA)
Musa, Hind Muzhir. Interleukin (IL) 17 expression in Iraqi bladder carcinoma patients. Iraqi Journal of Biotechnology Vol. 16, no. 3 (2017), pp.94-97.
https://search.emarefa.net/detail/BIM-811018
American Medical Association (AMA)
Musa, Hind Muzhir. Interleukin (IL) 17 expression in Iraqi bladder carcinoma patients. Iraqi Journal of Biotechnology. 2017. Vol. 16, no. 3, pp.94-97.
https://search.emarefa.net/detail/BIM-811018
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 97
Record ID
BIM-811018
